These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine. Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK. Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546 [Abstract] [Full Text] [Related]
6. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM. J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [Abstract] [Full Text] [Related]
7. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis. Nguyen TM, Daubard M, Le Gall C, Larger M, Lachaux A, Boulieu R. Ther Drug Monit; 2010 Aug; 32(4):433-7. PubMed ID: 20479703 [Abstract] [Full Text] [Related]
8. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y. J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197 [Abstract] [Full Text] [Related]
9. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM. Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256 [Abstract] [Full Text] [Related]
14. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease. Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK. Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923 [Abstract] [Full Text] [Related]
15. Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD. Kopylov U, Battat R, Benmassaoud A, Paradis-Surprenant L, Seidman EG. Dig Dis Sci; 2015 Feb; 60(2):478-84. PubMed ID: 25236422 [Abstract] [Full Text] [Related]
16. Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine. Lee MN, Kang B, Choi SY, Kim MJ, Woo SY, Kim JW, Choe YH, Lee SY. Inflamm Bowel Dis; 2015 Dec; 21(12):2897-908. PubMed ID: 26332308 [Abstract] [Full Text] [Related]
17. A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease. Mogensen DV, Brynskov J, Ainsworth MA, Nersting J, Schmiegelow K, Steenholdt C. J Crohns Colitis; 2018 Feb 28; 12(3):298-305. PubMed ID: 29145599 [Abstract] [Full Text] [Related]
18. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels. Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, Schwab M, Reinisch W. Inflamm Bowel Dis; 2013 Mar 28; 19(3):590-8. PubMed ID: 23388543 [Abstract] [Full Text] [Related]
19. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients. Gao X, Zhang FB, Ding L, Liu H, Wang XD, Chen BL, Bi HC, Xiao YL, Zhao LZ, Chen MH, Huang M, Hu PJ. Eur J Gastroenterol Hepatol; 2012 Aug 28; 24(8):958-64. PubMed ID: 22664938 [Abstract] [Full Text] [Related]
20. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study. Meijer B, Wilhelm AJ, Mulder CJJ, Bouma G, van Bodegraven AA, de Boer NKH. Ther Drug Monit; 2017 Aug 28; 39(4):399-405. PubMed ID: 28489727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]